Parkman Healthcare Partners LLC Replimune Group, Inc. Transaction History
Parkman Healthcare Partners LLC
- $708 Million
- Q3 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 763,747 shares of REPL stock, worth $10.9 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
763,747
Previous 525,000
45.48%
Holding current value
$10.9 Million
Previous $4.73 Million
77.14%
% of portfolio
1.18%
Previous 0.7%
Shares
2 transactions
Others Institutions Holding REPL
# of Institutions
150Shares Held
68.1MCall Options Held
52.3KPut Options Held
80.3K-
Baker Bros. Advisors LP New York, NY11MShares$157 Million1.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.88MShares$141 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$69.3 Million9.16% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$68.1 Million3.43% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$67.2 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $703M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...